biologics Flashcards
(42 cards)
what are mAbs
proteins
Therapeutic mAbs have been developed to block signals, kill cells, and activate receptors
A single rearranged antibody is selected that binds to desired antigen
what is antigen?
Antigen = something bound by an antibody
what is antibody?
Antibody = molecule made by B lymphocytes that binds to an antigen
what is “Polyclonal antiserum”
serum from animal immunised against an antigen (e.g. antivenom)
what is “Monoclonal Antibody” “mAb”
= single antibody molecule against a single antigen
antivenom vs/to mAbs
antivenom
- mixture of all antibodies
horse protein
made in animals
made by animal immune response
mAb (clever molecular biologist)
-only one antibody
-human protein
-made in bioreactor
-engineered by molecular biologists
examples of therapeutic mAbs
Mouse/rat monoclonal antibody
Mouse & human antibody DNA mixture- Chimeric
Human antibody with binding site from mouse mAb- Humanized
Human mAb (made from human
what are the 2 main classes of therapeutic protein
examles
proteins and peptides
monoclonal antibodies
p and monoclonal
Insulin - Herceptin
Growth hormone- Rituximab
Clotting/blood factors - Infliximab
What makes mAbs special?
mAbs are proteins- therefore unstable (structural, chemical)
BUT the antibody molecule is far more stable than other therapeutic proteins
Serum half-life far higher than most other therapeutic proteins- antibody molecule can last weeks!
Molecular weight higher than most other therapeutic proteins – bioavailibilty very limited except by i.v.
Dose and route administered differ:
High activity, potent therapeutic proteins- low doses, s.c.
mAbs - higher doses, i.v. infusion (but some s.c. e.g. Humira)
Why are mAb doses so high?
Molecular weight 100-1000x higher than small molecule
Therapeutic mechanism of action
Block (Herceptin- blocks growth factor receptor
Kill (Rituximab- kills leukemia B cells
Example of dose
e.g. around 500mg Rituximab infused at a rate of 50-400mg/hour
Treatment: weekly for 4-8 weeks
(contrast with insulin: 1 Unit is 45micrograms; high dose of 10 Units would be 0.5mg)
High cost:
Laboratory antibodies cost £100 per mg!
Rituximab: £873 for 50ml of 10mg/ml (i.e. 500mg)
formulation of mAbs
- high conc of mab
-Excipients added to reduce aggregation
Lyophilised mAbs must be dissolved to produce solution for injection;
Once dissolved, short storage life
Future advances:
- pre-filled syringes
- reduce injection volumes (very high protein concentration)
- ‘domain’ mAbs made from subunits of whole antibody
what is damage caused by
damage is caused by adaptive immune mechanisms
and
no hazard can be identified
how can you classify by source of antigen
External = hypersensitivity
Internal = autoimmunity
how can you classify by effector mechanism causing immunopathology?
Antibody type
T cell
what are the classifications of hypersensitivity
class - effector mechanism - example
I - IgE antibody on mast cells - Hayfever, asthma, anaphylaxis
II- IgM and IgG antibody mediated cell killing- Mismatched blood transfusion, Penicillin, Haemolytic anemia of the newborn
III- IgG antibody immune complexes- Serum sickness, long-term mAb use
IV- T cells- Contact dermatitis
Factors that affect immunogenicity:
Type of biologics (proteins especially likely target)
Sequence origin (human safer)
Origin of protein (mammalian cells best)
DELIVERY
e.g. Erythropoetin: subcutaneous = high risk
FORMULATION
Aggregation especially critical
Aggregation driven by denaturation, surfaces, silicone oil, incorrect storage
what are biomacromolecules
Biomacromolecules used as drugs – rather than small molecules
check one note
what are biomacromolecules
Biomacromolecules used as drugs – rather than small molecules
check one note
what is a biologic
created by either a microorganism or mamalian cell
large complex molecules, most of which are proteins or polypeptides
activity may be affected by the cell system in which it is produced, the fermentation media, or operating conditions.
have a complex production process that tends to yield small quantities.
Biologics are often extremely sensitive to physical conditions (temperature, shear forces, chemical phase, and light) and enzymatic action.
They usually require complex bioassays for batch release and stability assessment
what is biosimilar
biological function similar to ‘original approved drug’
Have to prove functionally equivalent by clinical evaluation
Generic: is chemically identical to branded drug
what is he difference between traditional small molecules and biologicals
small moleculw - aspirin
biologicals - monoclonal antibody - flu vaccine
why is the manufacture so complex for biologics and what is the manufacturing requirements
Due to:
Fragility of biological macromolecules
Sensitivity of the living cells that produce biologics
Often heterogeneous in the molecules and/or polypeptides present
Impurity profile that depends on the processes used to make and test each batch.
Therefore complex manufacturing requirements for
fermentation
aseptic processing
storage
testing
4 categories of biologics examples and use
why use biomacromolecules
gene therapy - nuceleic acid (gendicine) - only way to modify patients geonomes
proteins and peptides - Insulin, Growth hormone and Clotting/blood factors - Closest replacement of endogenous proteins
monoclonal antibodies - Herceptin, Rituximab and Infliximab - Ability to bind any antigen target Range of effects Common formulations and delivery for all mAbs
vaccines - Mixture of lipids, polypeptides, nucleic acids (Influenza vaccine, BCG tuberculosis vaccine and Hepatitis B vaccine) - Only way to protect individuals and populations from infectious diseases
General ‘pharmaceutics’ challenges for biomacromolecules
what are the complexities
Complexity of biologics higher than typical drugs
- molecular complexity
-functional complexity
-complex composition
more to ho wrong, more expensive to manufacture
Instability of biomacromolecules inherent due to biological origin
Availability often limited by large molecular size
Immunogenicity immune response to drug (hypersensitivity) can lead to loss of efficacy and more serious adverse effects